BTW
NEOG icon

Boston Trust Walden’s Neogen NEOG Stock Holding History

Boston Trust Walden’s Portfolio NEOG Stock Details NEOG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q2 		– Sell
-819,816
Closed -$13.8M – 338
2014
Q1 		$13.8M Sell
819,816
-26,779
-3% -$438K 0.21% 161
2013
Q4 		$14.5M Sell
846,595
-424,293
-33% -$7.38M 0.21% 160
2013
Q3 		$19.3M Sell
1,270,888
-19,860
-2% -$284K 0.3% 141
2013
Q2 		$17.9M Buy
+1,290,748
New +$17M 0.29% 149

Other funds holding NEOG

BCM
Brown Capital Management Baltimore, Maryland $500M AUM 25.3% 1-Year Est. Return
RP
Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
CCA
Conestoga Capital Advisors Wayne, Pennsylvania $4.6B AUM 16.08% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
SIMG
Stephens Investment Management Group Houston, Texas $9.33B AUM 56.1% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return

Boston Trust Walden's NEOG Position: Q2 2014 in Review

Boston Trust Walden sold out of Neogen (NEOG) in Q2 2014, closing a stake of 819,816 shares — an estimated $13.8M sold.

Boston Trust Walden first reported a position in NEOG in Q2 2013 and held it in 4 quarters. The position peaked at $19.3M in Q3 2013. 182 funds tracked by Wall St. Rank hold NEOG as of Q2 2014.

  • Boston Trust Walden reported no remaining Neogen position as of Q2 2014 after selling out during the quarter.
  • Boston Trust Walden sold 819,816 Neogen shares in Q2 2014, an estimated $13.8M.
  • Boston Trust Walden first reported a position in Neogen in Q2 2013 and held it in 4 quarters.
  • Boston Trust Walden's Neogen position peaked at $19.3M in Q3 2013.
  • 182 funds tracked by Wall St. Rank held Neogen as of Q2 2014.

Based on Boston Trust Walden's 13F filing for Q2 2014, filed 1 Aug 2014.